CA2866260A1 - Herbal composition for the treatment of metabolic disorders - Google Patents

Herbal composition for the treatment of metabolic disorders Download PDF

Info

Publication number
CA2866260A1
CA2866260A1 CA2866260A CA2866260A CA2866260A1 CA 2866260 A1 CA2866260 A1 CA 2866260A1 CA 2866260 A CA2866260 A CA 2866260A CA 2866260 A CA2866260 A CA 2866260A CA 2866260 A1 CA2866260 A1 CA 2866260A1
Authority
CA
Canada
Prior art keywords
extract
composition
plant
calophyllum
metabolic disorder
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA2866260A
Other languages
English (en)
French (fr)
Inventor
Arvind Saklani
Parikshit GAIKWAD
Aslam BURHAN
Somesh Sharma
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Piramal Enterprises Ltd
Original Assignee
Piramal Enterprises Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Piramal Enterprises Ltd filed Critical Piramal Enterprises Ltd
Publication of CA2866260A1 publication Critical patent/CA2866260A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/38—Clusiaceae, Hypericaceae or Guttiferae (Hypericum or Mangosteen family), e.g. common St. Johnswort
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Endocrinology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Emergency Medicine (AREA)
  • Reproductive Health (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Child & Adolescent Psychology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicinal Preparation (AREA)
CA2866260A 2012-03-13 2013-03-12 Herbal composition for the treatment of metabolic disorders Abandoned CA2866260A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261610002P 2012-03-13 2012-03-13
US61/610,002 2012-03-13
PCT/IB2013/051925 WO2013136257A1 (en) 2012-03-13 2013-03-12 Herbal composition for the treatment of metabolic disorders

Publications (1)

Publication Number Publication Date
CA2866260A1 true CA2866260A1 (en) 2013-09-19

Family

ID=49160323

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2866260A Abandoned CA2866260A1 (en) 2012-03-13 2013-03-12 Herbal composition for the treatment of metabolic disorders

Country Status (13)

Country Link
US (1) US20150050373A1 (OSRAM)
EP (1) EP2825183A4 (OSRAM)
JP (1) JP2015509976A (OSRAM)
KR (1) KR20140138275A (OSRAM)
CN (1) CN104203258A (OSRAM)
AU (1) AU2013233930A1 (OSRAM)
CA (1) CA2866260A1 (OSRAM)
IL (1) IL234616A0 (OSRAM)
IN (1) IN2014MN01933A (OSRAM)
MX (1) MX2014010926A (OSRAM)
NZ (1) NZ630125A (OSRAM)
RU (1) RU2014140852A (OSRAM)
WO (1) WO2013136257A1 (OSRAM)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10588974B2 (en) 2016-04-22 2020-03-17 Receptor Holdings, Inc. Fast-acting plant-based medicinal compounds and nutritional supplements
EA201892396A1 (ru) 2016-12-02 2019-04-30 Ресептор Лайф Сайенсиз, Инк. Быстродействующие растительные лекарственные соединения и биологически активные добавки
UY38480A (es) 2018-11-19 2020-06-30 Receptor Holdings Inc Aminoácidos grasos n-acilados para reducir la variabilidad de absorción en composiciones a base de cannabinoides
WO2020214565A1 (en) * 2019-04-15 2020-10-22 Board Of Regents, The University Of Texas System Calibration methods and compositions for biomolecule analysis

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5211944A (en) * 1990-10-12 1993-05-18 Shaman Pharmaceuticals, Inc. Proanthocyanidin polymers having antiviral activity and methods of obtaining same
US6774141B1 (en) * 1992-03-31 2004-08-10 The United States Of America As Represented By The Secretary Of Health And Human Services Calanolide and related antiviral compounds, compositions, and uses thereof
EP0935417B1 (en) * 1996-10-16 2009-05-06 Napo Pharmaceuticals, Inc. Enteric formulations of proanthocyanidin polymer antidiarrheal compositions
US6004996A (en) * 1997-02-05 1999-12-21 Hoffman-La Roche Inc. Tetrahydrolipstatin containing compositions
FR2794973B1 (fr) * 1999-06-18 2001-09-14 Mousny Brigitte Utilisation d'huile de plantes du genre calophyllum extraite a temperature ambiante dans des compositions cosmetiques, dietetiques et therapeutiques
JP2001192317A (ja) * 2000-01-06 2001-07-17 Shiseido Co Ltd マトリックスメタロプロテアーゼ阻害剤
JP2005272326A (ja) * 2004-03-23 2005-10-06 A Pharma Kindai Co Ltd 抗アレルギー剤、抗掻痒剤、及び抗菌剤
FR2886547B1 (fr) * 2005-06-02 2009-06-05 Boucher Claude Henri Marie Ghi Composition cosmetique, dietetique, pharmaceutique obtenue a partir d'huile non raffinee exempte d'acides gras trans, d'esters phorboliques, extraite sans solvant
EP2529626B1 (en) * 2006-05-01 2017-11-22 Napo Pharmaceuticals, Inc. Compositions and methods for treating or preventing colon cancer
JP2008081440A (ja) * 2006-09-27 2008-04-10 Noevir Co Ltd アロマターゼ活性促進剤
EP2121671A1 (en) * 2006-12-20 2009-11-25 Novartis AG 2-substituted 5-membered heterocycles as scd inhibitors
FR2915095B1 (fr) * 2007-04-17 2013-08-23 Diaye Yacine Isabelle Monique N Creme de soin
WO2010065528A2 (en) * 2008-12-02 2010-06-10 Kreations By Kristin, L.C. Gymnema-containing lip balm compositions and associated methods
US8821948B2 (en) * 2010-03-04 2014-09-02 Steva A. Komeh-Nkrumah Therapeutic, bio-affecting and body treating composition

Also Published As

Publication number Publication date
JP2015509976A (ja) 2015-04-02
CN104203258A (zh) 2014-12-10
EP2825183A4 (en) 2015-09-23
IN2014MN01933A (OSRAM) 2015-07-10
US20150050373A1 (en) 2015-02-19
IL234616A0 (en) 2014-11-30
WO2013136257A1 (en) 2013-09-19
AU2013233930A1 (en) 2014-09-25
KR20140138275A (ko) 2014-12-03
EP2825183A1 (en) 2015-01-21
NZ630125A (en) 2017-01-27
MX2014010926A (es) 2015-04-10
RU2014140852A (ru) 2016-05-10

Similar Documents

Publication Publication Date Title
AU2013254329A1 (en) Composition for treating metabolic disorders
JP6449448B2 (ja) ボタンの根皮、アンジェリカ・ダフリカの根、及びミシマサイコの根又はそれらの画分を有効成分として含有する神経変性障害の治療及び予防のための医薬組成物
KR100523562B1 (ko) 손바닥선인장 추출물 및 이로부터 분리된 화합물을함유하는 신경세포 보호용 조성물
AU2013233930A1 (en) Herbal composition for the treatment of metabolic disorders
US20020122836A1 (en) Selective COX-2 inhibition from non-edible plant extracts
JP6758799B2 (ja) 医薬組成物
CN103301179B (zh) 杜仲木脂素提取物在制备用于防治高甘油三脂血症的药物中的应用
US7731994B2 (en) Pharmaceutical composition for protecting neurons comprising extract of lithospermum erythrothizon SIEB. ET. Zucc or acetylshikonin isolated therefrom as an effective ingredient
US20060246161A1 (en) Method of making medicament for treating anemia
US20070104811A1 (en) Pharmaceutical composition useful for the treatment of prostate cancer
KR100947377B1 (ko) 돌단풍 추출물 또는 이로부터 분리된 트리테르펜 화합물을포함하는 대사성 질환의 예방 또는 치료용 약학 조성물
CN104856986A (zh) 5-羟甲基糠醛在制备抗肝纤维化药物中的新用途
CN114736182A (zh) 一种抗心肌缺血再灌注损伤的化合物和傣药组合物及其应用
CN101590120B (zh) 一种中药组合物在制备增殖人体外周血内皮祖细胞的药物中的应用
KR100697235B1 (ko) 관동화 추출물 또는 투실라곤을 포함하는 비만 및 제2형당뇨병 예방 및 치료용 조성물
JP2008542254A (ja) 肝細胞癌の処置に有用な医薬組成物
KR102532265B1 (ko) 돌단풍(Aceriphyllum rossii) 유래 3-하이드록시올레안-12-엔-27-오익산 또는 그의 유도체를 포함하는 골 용해성 질환의 예방 또는 치료용 조성물
EP3283094B1 (en) Use of a withania extract for the treatment of alpha synucleinopathies
KR100668172B1 (ko) 물오리나무 추출물 또는 베툴리닉에시드를 포함하는 비만및 제2형 당뇨병 예방 및 치료용 조성물
Lee et al. Immunomodulatory activity of Ulmus davidiana Planch (Ulmaceae) water and ethanolic extracts on bone cells: Stimulation of proliferation, alkaline phosphatase activity and type I collagen synthesis
US20040062823A1 (en) Selective cox-2 inhibition from non-edible plant extracts
CN121370926A (zh) 一种治疗和/或预防抑郁症的药物组合物及其制备方法、应用
WO2022180207A1 (en) An extract from a plant species of the subfamily cichorioideae for use in the prevention or treatment of covid-19
Tiwari Cardioprotective Activity of Amritarishta on Isoproterenol Induced Myocardial Infarction
Salawu et al. Influence of Oral Administration of Peppermint Tea on Biochemical and Histological Markers of the Liver of Wistar Rats

Legal Events

Date Code Title Description
FZDE Discontinued

Effective date: 20180313